Nutritional Supplements and Functional Foods: Functional Significance and Global Regulations

Nutraceutical and Functional Food Regulations in the United States and Around the World

Volumn , Issue , 2008, Pages 11-35

  Hänninen, Osmo ^a   Sen, Chandan K ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884447077     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373901-8.00002-0     Document Type: Chapter

References (163)

1. Brillat Savarin A. (1965). Physiologie du gout (J-F Revel) Paris.
2. Tovey FI, Hobsley M Milling of wheat, maize and rice: effects on fibre and lipid content and health. World J Gastroenterol. 2004, 10:1695-1696.
3. Burdock GA, Carabin IG, Griffiths JC The importance of GRAS to the functional food and nutraceutical industries. Toxicology 2006, 221:17-27.
4. Choi YM, Bae SH, Kang DH, Suh HJ Hypolipidemic effect of lactobacillus ferment as a functional food supplement. Phytother Res 2006, 20:1056-1060.
5. Olmedilla-Alonso B, Granado-Lorencio F, Herrero-Barbudo C, Blanco-Navarro I Nutritional approach for designing meat-based functional food products with nuts. Crit Rev Food Sci Nutr 2006, 46:537-542.
6. Sieber CC [Functional food in elderly persons.]. Ther Umsch 2007, 64:141-146.
7. Fitch K, Pyenson B, Iwasaki K Metabolic syndrome and employer sponsored medical benefits: an actuarial analysis. Value Health 2007, 10(Suppl 1):S21-s28.
8. Poitout V, Hagman D, Stein R, Artner I, Robertson RP, Harmon JS Regulation of the insulin gene by glucose and fatty acids. J Nutr 2006, 136:873-876.
9. Jatoi S.A., Kikuchi A., Gilani S.A., Watanabe K.N. Phytochemical, pharmacological and ethnobotanical studies in mango ginger (Curcuma amada Roxb.; Zingiberaceae). Phytother Res 2007.
10. Hill J.O., Peters J.C., Wyatt H.R. The role of public policy in treating the epidemic of global obesity**. Clin Pharmacol Ther 2007.
11. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006, 368:1681-1688.
12. Dymsza HA Nutritional application and implication of 1,3-butanediol. Fed Proc 1975, 34:2167-2170.
13. Ashwell M. (2002). Concepts of Functional Foods. ILSI Europe Concise Monograph Series,.
14. Ohama H, Ikeda H, Moriyama H Health foods and foods with health claims in Japan. Toxicology 2006, 221:95-111.
15. Aggett PJ, Antoine JM, Asp NG, et al. PASSCLAIM: consensus on criteria. Eur J Nutr 2005, 44(Suppl 1):I5-I30.
16. Asp NG, Contor L Process for Assessment of Scientific Support for Claims on Food (PASSCLAIM): overall introduction. Eur J Nutr 2003, 42(Suppl 1):I3-i15.
17. Contor L, Asp NG Process for the assessment of scientific support for claims on foods (PASSCLAIM) phase two: moving forward. Eur J Nutr 2004, 43(Suppl 2):II3-II6.
18. Cummings JH, Antoine JM, Azpiroz F, et al. PASSCLAIM - gut health and immunity. Eur J Nutr 2004, 43(Suppl 2):II118-II173.
19. Cummings JH, Pannemans D, Persin C PASSCLAIM - Report of First Plenary Meeting including a set of interim criteria to scientifically substantiate claims on foods. Eur J Nutr 2003, 42(Suppl 1):I112-i119.
20. Howlett J, Shortt C PASSCLAIM - report of the second plenary meeting: review of a wider set of interim criteria for the scientific substantiation of health claims. Eur J Nutr 2004, 43(Suppl 2):II174-II183.
21. Mensink RP, Aro A, Den Hond E, et al. PASSCLAIM - Diet-related cardiovascular disease. Eur J Nutr 2003, 42(Suppl 1):I6-i27.
22. Prentice A, Bonjour JP, Branca F, et al. PASSCLAIM - Bone health and osteoporosis. Eur J Nutr 2003, 42(Suppl 1):I28-i49.
23. Rafter J, Govers M, Martel P, et al. PASSCLAIM - diet-related cancer. Eur J Nutr 2004, 43(Suppl 2):II47-iI84.
24. Riccardi G, Aggett P, Brighenti F, et al. PASSCLAIM - body weight regulation, insulin sensitivity and diabetes risk. Eur J Nutr 2004, 43(Suppl 2):II7-II46.
25. Richardson DP, Affertsholt T, Asp NG, et al. PASSCLAIM - Synthesis and review of existing processes. Eur J Nutr 2003, 42(Suppl 1):I96-i111.
26. Saris WH, Antoine JM, Brouns F, et al. PASSCLAIM - Physical performance and fitness. Eur J Nutr 2003, 42(Suppl 1):I50-i95.
27. Westenhoefer J, Bellisle F, Blundell JE, et al. PASSCLAIM - mental state and performance. Eur J Nutr 2004, 43(Suppl 2):II85-II117.
28. Erdman JW, Jr., Balentine D, Arab L et al. (2007). Flavonoids and Heart Health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 137, 718S-737S.
29. Saito M Role of FOSHU (food for specified health uses) for healthier life. Yakugaku Zasshi 2007, 127:407-416.
30. Kinzie MB Instructional design strategies for health behavior change. Patient Educ Couns 2005, 56:3-15.
31. Colella C, Laver J Setting the stage for changing health behavior. Nurse Pract 2005, 30:68-70.
32. Nieuwenhuijsen ER, Zemper E, Miner KR, Epstein M Health behavior change models and theories: contributions to rehabilitation. Disabil Rehabil 2006, 28:245-256.
33. Pietinen P, Nissinen A, Vartiainen E, et al. Dietary changes in the North Karelia Project (1972-1982). Prev Med 1988, 17:183-193.
34. Puska P, Koskela K, Pakarinen H, Puumalainen P, Soininen V, Tuomilehto J The North Karelia Project: a programme for community control of cardiovascular diseases. Scand J Soc Med 1976, 4:57-60.
35. Pietinen P, Lahti-Koski M, Vartiainen E, Puska P Nutrition and cardiovascular disease in Finland since the early 1970s: a success story. J Nutr Health Aging 2001, 5:150-154.
36. Katina K, Laitila A, Juvonen R, et al. Bran fermentation as a means to enhance technological properties and bioactivity of rye. Food Microbiol 2007, 24:175-186.
37. Dikeman CL, Fahey GC Viscosity as related to dietary fiber: a review. Crit Rev Food Sci Nutr 2006, 46:649-663.
38. Rock CL Primary dietary prevention: is the fiber story over?. Recent Results Cancer Res 2007, 174:171-177.
39. Rose DJ, DeMeo MT, Keshavarzian A, Hamaker BR Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr Rev 2007, 65:51-62.
40. Keenan MJ, Zhou J, McCutcheon KL, et al. Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 2006, 14:1523-1534.
41. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006, 40:235-243.
42. Adlercreutz H, Heinonen SM, Penalvo-Garcia J Phytoestrogens, cancer and coronary heart disease. Biofactors 2004, 22:229-236.
43. Hallmans G, Zhang JX, Lundin E, et al. Rye, lignans and human health. Proc Nutr Soc 2003, 62:193-199.
44. Linko AM, Juntunen KS, Mykkanen HM, Adlercreutz H Whole-grain rye bread consumption by women correlates with plasma alkylresorcinols and increases their concentration compared with low-fiber wheat bread. J Nutr 2005, 135:580-583.
45. Hagander B, Bjorck I, Asp NG, et al. Rye products in the diabetic diet. Postprandial glucose and hormonal responses in non-insulin-dependent diabetic patients as compared to starch availability in vitro and experiments in rats. Diabetes Res Clin Pract 1987, 3:85-96.
46. Leinonen KS, Poutanen KS, Mykkanen HM Rye bread decreases serum total and LDL cholesterol in men with moderately elevated serum cholesterol. J Nutr 2000, 130:164-170.
47. Bertram HC, Duarte IF, Gil AM, Knudsen KE, Laerke HN Metabolic profiling of liver from hypercholesterolemic pigs fed rye or wheat fiber and from normal pigs. High-resolution magic angle spinning 1H NMR spectroscopic study. Anal Chem 2007, 79:168-175.
48. Landberg R, Linko AM, Kamal-Eldin A, Vessby B, Adlercreutz H, Aman P Human plasma kinetics and relative bioavailability of alkylresorcinols after intake of rye bran. J Nutr 2006, 136:2760-2765.
49. Andersson M, Ellegard L, Andersson H Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one. Am J Clin Nutr 2002, 76:1111-1116.
50. Brighenti F, Casiraghi MC, Ciappellano S, Crovetti R, Testolin G Digestibility of carbohydrates from rice-, oat- and wheat-based ready-to-eat breakfast cereals in children. Eur J Clin Nutr 1994, 48:617-624.
51. Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 1996, 96:1254-1261.
52. Murphy EA, Davis JM, Brown AS, Carmichael MD, Ghaffar A, Mayer EP Oat beta-glucan effects on neutrophil respiratory burst activity following exercise. Med Sci Sports Exerc 2007, 39:639-644.
53. Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007, 6:6.
54. Reyna-Villasmil N, Bermudez-Pirela V, Mengual-Moreno E, et al. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 2007, 14:203-212.
55. Biorklund M, van Rees A, Mensink RP, Onning G Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial. Eur J Clin Nutr 2005, 59:1272-1281.
56. Braaten JT, Wood PJ, Scott FW, Riedel KD, Poste LM, Collins MW Oat gum lowers glucose and insulin after an oral glucose load. Am J Clin Nutr 1991, 53:1425-1430.
57. Tapola N, Karvonen H, Niskanen L, Mikola M, Sarkkinen E Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2005, 15:255-261.
58. Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994, 48:465-474.
59. Theuwissen E, Mensink RP Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 2007, 137:583-588.
60. Boehm G, Stahl B, Jelinek J, Knol J, Miniello V, Moro GE Prebiotic carbohydrates in human milk and formulas. Acta Paediatr Suppl 2005, 94:18-21.
61. Cashman KD A prebiotic substance persistently enhances intestinal calcium absorption and increases bone mineralization in young adolescents. Nutr Rev 2006, 64:189-196.
62. Corcoran BM, Ross RP, Fitzgerald GF, Stanton C Comparative survival of probiotic lactobacilli spray-dried in the presence of prebiotic substances. J Appl Microbiol 2004, 96:1024-1039.
63. Schoonen M, Smirnov A, Cohn C A perspective on the role of minerals in prebiotic synthesis. Ambio 2004, 33:539-551.
64. Burt BA The use of sorbitol- and xylitol-sweetened chewing gum in caries control. J Am Dent Assoc 2006, 137:190-196.
65. Granstrom TB, Izumori K, Leisola M A rare sugar xylitol. Part I: the biochemistry and biosynthesis of xylitol. Appl Microbiol Biotechnol 2007, 74:277-281.
66. Granstrom TB, Izumori K, Leisola M A rare sugar xylitol. Part II: biotechnological production and future applications of xylitol. Appl Microbiol Biotechnol 2007, 74:273-276.
67. Kitchens DH Xylitol in the prevention of oral diseases. Spec Care Dentist 2005, 25:140-144.
68. Ly KA, Milgrom P, Rothen M Xylitol, sweeteners. and dental caries, Pediatr Dent 2006, 28:154-163. discussion, 192-158.
69. Duthie GG, Gardner PT, Kyle JA Plant polyphenols: are they the new magic bullet?. Proc Nutr Soc 2003, 62:599-603.
70. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
71. Scalbert A, Johnson IT, Saltmarsh M Polyphenols: antioxidants and beyond. Am J Clin Nutr 2005, 81:215S-217S.
72. Halliwell B Dietary polyphenols: good, bad, or indifferent for your health?. Cardiovasc Res 2007, 73:341-347.
73. Dormandy TL Free-radical reaction in biological systems. Ann R Coll Surg Engl 1980, 62:188-194.
74. Emanuel NM Kinetics and free-radical mechanisms of ageing and carcinogenesis. IARC Sci Publ, 1985, 127-150.
75. Harman D Prolongation of life: role of free radical reactions in aging. J Am Geriatr Soc 1969, 17:721-735.
76. Slater TF Free-radical mechanisms in tissue injury. Biochem J 1984, 222:1-15.
77. Cordier JF Oxidant-antioxidant balance. Bull Eur Physiopathol Respir 1987, 23:273-274.
78. Frankel EN The antioxidant and nutritional effects of tocopherols, ascorbic acid and beta-carotene in relation to processing of edible oils. Bibl Nutr Dieta, 1989, 297-312.
79. Godin DV, Wohaieb SA Nutritional deficiency, starvation, and tissue antioxidant status. Free Radic Biol Med 1988, 5:165-176.
80. Halliwell B How to characterize a biological antioxidant. Free Radic Res Commun 1990, 9:1-32.
81. Clemens MR Antioxidant therapy in hematological disorders. Adv Exp Med Biol 1990, 264:423-433.
82. Grimes JD, Hassan MN, Thakar J Antioxidant therapy in Parkinson's disease. Can J Neurol Sci 1987, 14:483-487.
83. Hearse DJ Prospects for antioxidant therapy in cardiovascular medicine. Am J Med 1991, 91:118S-s121S.
84. Jackson MJ, Edwards RH Free radicals and trials of antioxidant therapy in muscle diseases. Adv Exp Med Biol 1990, 264:485-491.
85. Muller DP Antioxidant therapy in neurological disorders. Adv Exp Med Biol 1990, 264:475-484.
86. Rice-Evans CA, Diplock AT Current status of antioxidant therapy. Free Radic Biol Med 1993, 15:77-96.
87. Schiller HJ, Reilly PM, Bulkley GB Tissue perfusion in critical illnesses. Antioxidant therapy. Crit Care Med 1993, 21:S92-102.
88. Uden S, Bilton D, Guyan PM, Kay PM, Braganza JM Rationale for antioxidant therapy in pancreatitis and cystic fibrosis. Adv Exp Med Biol 1990, 264:555-572.
89. Yoshikawa T, Naito Y, Kondo M Antioxidant therapy in digestive diseases. J Nutr Sci Vitaminol (Tokyo) 1993, 39(Suppl):S35-41.
90. Youn YK, LaLonde C, Demling R Use of antioxidant therapy in shock and trauma. Circ Shock 1991, 35:245-249.
91. Hennekens CH Antioxidant vitamins and cancer. Am J Med 1994, 97:2S-s4S. discussion 22S-28S.
92. Clifton PM Antioxidant vitamins and coronary heart disease risk. Curr Opin Lipidol 1995, 6:20-24.
93. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995, 123:860-872.
94. Meyers DG, Maloley PA, Weeks D Safety of antioxidant vitamins. Arch Intern Med 1996, 156:925-935.
95. Lonn EM, Yusuf S Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data. Can J Cardiol 1997, 13:957-965.
96. Bland JS The pro-oxidant and antioxidant effects of vitamin C. Altern Med Rev 1998, 3:170.
97. Halliwell B The antioxidant paradox. Lancet 2000, 355:1179-1180.
98. Bowry VW, Ingold KU, Stocker R Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J 1992, 288(Pt 2):341-344.
99. Halliwell B Vitamin C: antioxidant or pro-oxidant in vivo?. Free Radic Res 1996, 25:439-454.
100. Laughton MJ, Halliwell B, Evans PJ, Hoult JR Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem Pharmacol 1989, 38:2859-2865.
101. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J Vitamin C exhibits pro-oxidant properties. Nature 1998, 392:559.
102. Spencer JP, Jenner A, Butler J, et al. Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease. Free Radic Res 1996, 24:95-105.
103. Truscott TG Beta-carotene and disease: a suggested pro-oxidant and anti-oxidant mechanism and speculations concerning its role in cigarette smoking. J Photochem Photobiol B 1996, 35:233-235.
104. Wolff SP, Spector A Pro-oxidant activation of ocular reductants. 2. Lens epithelial cell cytotoxicity of a dietary quinone is associated with a stable free radical formed with glutathione in vitro. Exp Eye Res 1987, 45:791-803.
105. Wolff SP, Wang GM, Spector A Pro-oxidant activation of ocular reductants. 1. Copper and riboflavin stimulate ascorbate oxidation causing lens epithelial cytotoxicity in vitro. Exp Eye Res 1987, 45:777-789.
106. Yeh S, Hu M Antioxidant and pro-oxidant effects of lycopene in comparison with beta-carotene on oxidant-induced damage in Hs68 cells. J Nutr Biochem 2000, 11:548-554.
107. Carlson JC, Sawada M Generation of free radicals and messenger function. Can J Appl Physiol 1995, 20:280-288.
108. Llamas R [Hydrogen peroxide, the 2d messenger for insulin action on the metabolism of glucose and fat bodies in adipose tissue. Its effects on adrenaline lipolysis]. Gac Med Mex 1984, 120:109-112.
109. Sen CK Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 1998, 55:1747-1758.
110. Sen CK, Packer L Antioxidant and redox regulation of gene transcription. Faseb J 1996, 10:709-720.
111. Sun Y, Oberley LW Redox regulation of transcriptional activators. Free Radic Biol Med 1996, 21:335-348.
112. Biaglow JE, Miller RA The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Cancer Biol Ther 2005, 4:6-13.
113. Friedlich AL, Beal MF Prospects for redox-based therapy in neurodegenerative diseases. Neurotox Res 2000, 2:229-237.
114. Kinnula VL, Fattman CL, Tan RJ, Oury TD Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005, 172:417-422.
115. Pennington JD, Wang TJ, Nguyen P, et al. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy. Drug Resist Updat 2005, 8:322-330.
116. Roy S, Khanna S, Nallu K, Hunt TK, Sen CK Dermal wound healing is subject to redox control. Mol Ther 2006, 13:211-220.
117. Contor L., Asp NG. Process for the assessment of scientific support for claims on foods (PASSCLAIM) phase two: moving forward. Eur J Nutr 2004, 43(Suppl 2):II3-II6.
118. Cummings JH., Antoine JM., Azpiroz F., et al. PASSCLAIM - gut health and immunity. Eur J Nutr 2004, 43(Suppl 2):II118-iiII173.
119. Campbell FC, Collett GP Chemopreventive properties of curcumin. Future Oncol 2005, 1:405-414.
120. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC Multiple biological activities of curcumin: a short review. Life Sci 2006, 78:2081-2087.
121. Singh S, Khar A Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 2006, 6:259-270.
122. Thangapazham RL, Sharma A, Maheshwari RK Multiple molecular targets in cancer chemoprevention by curcumin. Aaps J 2006, 8:E443-e449.
123. Packer L, Weber SU, Rimbach G Molecular aspects of alpha-tocotrienol antioxidant action and cell signaling. J Nutr 2001, 131:369S-373S.
124. Sen CK, Khanna S, Roy S Tocotrienol: the natural vitamin E to defend the nervous system?. Ann NY Acad Sci 2004, 1031:127-142.
125. Theriault A, Chao JT, Wang Q, Gapor A, Adeli K Tocotrienol: a review of its therapeutic potential. Clin Biochem 1999, 32:309-319.
126. Erlund I, Freese R, Marniemi J, Hakala P, Alfthan G Bioavailability of quercetin from berries and the diet. Nutr Cancer 2006, 54:13-17.
127. Freese R Markers of oxidative DNA damage in human interventions with fruit and berries. Nutr Cancer 2006, 54:143-147.
128. Juranic Z, Zizak Z Biological activities of berries: from antioxidant capacity to anti-cancer effects. Biofactors 2005, 23:207-211.
129. Dyerberg J Coronary heart disease in Greenland Inuit: a paradox. Implications for western diet patterns. Arctic Med Res 1989, 48:47-54.
130. Jorgensen KA, Hoj Nielsen A, Dyerberg J Hemostatic factors and renin in Greenland Eskimos on a high eicosapentaenoic acid intake. Results of the Fifth UmanaK Expedition. Acta Med Scand 1986, 219:473-479.
131. Kris-Etherton PM, Harris WS, Appel LJ Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003, 23:e20-e30.
132. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006, 84:5-17.
133. Sands SA, Reid KJ, Windsor SL, Harris WS The impact of age,. body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 2005, 40:343-347.
134. Agren JJ, Hanninen OO Effect of moderate freshwater fish diet on erythrocyte ghost phospholipid fatty acids. Ann Med 1991, 23:261-263.
135. Sen CK, Atalay M, Agren J, Laaksonen DE, Roy S, Hanninen O Fish oil and vitamin E supplementation in oxidative stress at rest and after physical exercise. J Appl Physiol 1997, 83:189-195.
136. Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hanninen O, Uusitupa MI Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 1997, 32:697-705.
137. Agren JJ, Hanninen O, Julkunen A, et al. Fish diet. fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur J Clin Nutr 1996, 50:765-771.
138. Smith BK, Sun GY, Donahue OM, Thomas TR Exercise plus n-3 fatty acids: additive effect on postprandial lipemia. Metabolism 2004, 53:1365-1371.
139. Ruzickova J, Rossmeisl M, Prazak T, et al. Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 2004, 39:1177-1185.
140. Ghafoorunissa, Ibrahim A, Rajkumar L, Acharya V Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J Nutr 2005, 135:2634-2638.
141. Whelan J, Li B, Birdwell C Dietary arachidonic acid increases eicosanoid production in the presence of equal amounts of dietary eicosapentaenoic acid. Adv Exp Med Biol 1997, 400B:897-904.
142. Schuman BE, Squires EJ, Leeson S Effect of dietary flaxseed, flax oil and n-3 fatty acid supplement on hepatic and plasma characteristics relevant to fatty liver haemorrhagic syndrome in laying hens. Br Poult Sci 2000, 41:465-472.
143. Drain PK, Kupka R, Mugusi F, Fawzi WW Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am J Clin Nutr 2007, 85:333-345.
144. Karp SM, Koch TR Mechanisms of micronutrient deficiency. Dis Mon 2006, 52:208-210.
145. Neumann CG Symposium: food-based approaches to combating micronutrient deficiencies in children of developing countries. Background. J Nutr 2007, 137:1091-1092.
146. Rennie KL, Livingstone MB Associations between dietary added sugar intake and micronutrient intake: a systematic review. Br J Nutr 2007, 97:832-841.
147. Rennie KL, Livingstone MB Systematic review: associations between dietary added sugar intake and micronutrient intake. Br J Nutr, 2007, 1-10.
148. Shenkin A The key role of micronutrients. Clin Nutr 2006, 25:1-13.
149. Shenkin A Micronutrients in health and disease. Postgrad Med J 2006, 82:559-567.
150. Visioli F, Hagen TM Nutritional strategies for healthy cardiovascular aging: focus on micronutrients. Pharmacol Res 2007, 55:199-206.
151. Volpe SL Micronutrient requirements for athletes. Clin Sports Med 2007, 26:119-130.
152. Webb P, Nishida C, Darnton-Hill I Age and gender as factors in the distribution of global micronutrient deficiencies. Nutr Rev 2007, 65:233-245.
153. Key TJ, Appleby PN, Rosell MS Health effects of vegetarian and vegan diets. Proc Nutr Soc 2006, 65:35-41.
154. John S, Sorokin AV, Thompson PD Phytosterols and vascular disease. Curr Opin Lipidol 2007, 18:35-40.
155. Darbre A, Norris FW Vitamins in germination; determination of free and combined inositol in germinating oats. Biochem J 1956, 64:441-446.
156. Gardiner P Dietary supplement use in children: concerns of efficacy and safety. Am Fam Physician 2005, 71:1068-1071.
157. Knight J Safety concerns prompt US ban on dietary supplement. Nature 2004, 427:90.
158. Morrow JD, Edeki TI, El Mouelhi M, et al. American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther 2005, 77:113-122.
159. Yen PK Food and supplement safety. Geriatr Nurs 2005, 26:279-280.
160. Ziker D What lies beneath: an examination of the underpinnings of dietary supplement safety regulation. Am J Law Med 2005, 31:269-284.
161. Melby CL, Toohey ML, Cebrick J Blood pressure and blood lipids among vegetarian, semivegetarian, and nonvegetarian African Americans. Am J Clin Nutr 1994, 59:103-109.
162. Richardon DP Nutrition, health ageing and public policy 2007, Brussels: International Alliance of Dietary Food Supplement Associations (IADSA), Group ISpp. 1-71.
163. Kauhanen J, Myllykangas M, Salonen JT, Nissinen A Kansanterveystiede 1998, Porvoo: WSOY, Porvoo. 2nd edn.